/
Other
Impaired Glucose Tolerance
10
Pipeline Programs↗
3
Active Trials↗
14
Companies Involved↗
Impaired glucose tolerance is an early-stage landscape with 10 programs across 14 companies. The most active players are Haisco Pharmaceutical Group Co., Ltd..
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
Preclinical10
Phase 1
No programs
Phase 2
No programs
Phase 3
No programs
Approved
No programs
Analysis
Trial Status
38
clinical trials
Completed23 · 61%
Unknown status7 · 18%
Withdrawn4 · 11%
Recruiting2 · 5%
Not yet recruiting1 · 3%
Terminated1 · 3%
Clinical Trials
Trial Activity
38 trials
Pre-diabetes in Subject With Impaired Fasting Glucose (IFG) and Impaired Glucose Tolerance (IGT)
Recruiting·TThe University of Texas Health Science Center at San Antonio·N/A·NCT02969798·700 enrolled
Treatment of Impaired Glucose Tolerance in Pregnancy
Completed·—·N/A·NCT00625781·72 enrolled
Pilot Study of Resveratrol in Older Adults With Impaired Glucose Tolerance
Completed·—·N/A·NCT01375959·38 enrolled
Page 1 of 3
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)